Which myopathies cause elevated creatine kinase (CK) with normal aldolase?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Myopathies with Elevated CK but Normal Aldolase

The pattern of elevated creatine kinase (CK) with normal aldolase is most characteristic of muscular dystrophies, particularly Duchenne and Becker muscular dystrophy, as well as metabolic myopathies including glycogen storage diseases (types II, III, V, VII) and certain mitochondrial myopathies.

Key Diagnostic Pattern

The combination of CK, aldolase, and AST measurements creates a diagnostic algorithm that discriminates between different myopathy types 1. This enzyme pattern helps distinguish:

  • Muscular dystrophies: Markedly elevated CK with proportionally less aldolase elevation
  • Inflammatory myopathies: Both CK and aldolase elevated, with AST significantly elevated due to inflammation 1

Specific Myopathies with This Pattern

Muscular Dystrophies

Duchenne Muscular Dystrophy (DMD) presents with markedly increased CK concentrations—often the first laboratory abnormality detected, sometimes before clinical symptoms emerge 2. The CK elevation in DMD is profound and occurs early, while aldolase elevation is proportionally less prominent. Diagnosis should be considered in any male child with unexplained transaminase elevation before pursuing liver biopsy 2.

Becker muscular dystrophy shows similar but less severe enzyme patterns, with progressive proximal muscle weakness and elevated CK 3.

Glycogen Storage Diseases

Pompe disease (GSD II) demonstrates CK elevation as a sensitive marker, with the greatest elevation in infantile-onset patients (as high as 2000 IU/L) 3. Approximately 95% of late-onset patients have elevated CK, though some adults may have normal-range CK 3. The disease presents with progressive proximal muscle weakness, respiratory impairment, and in infantile forms, hypertrophic cardiomyopathy.

GSD type III (debrancher deficiency) causes muscle involvement with elevated CK concentrations, accompanied by hypoglycemia and hepatomegaly in children 4, 3. The muscle weakness can be both proximal and distal, distinguishing it from Pompe disease which primarily affects truncal and proximal muscles 4.

McArdle disease (GSD V) and Tauri disease (GSD VII) present with significantly elevated CK levels, exercise-induced muscle cramps, and propensity for rhabdomyolysis 4, 3.

Other Metabolic Myopathies

Mitochondrial myopathies can present with hypotonia, muscle weakness, and elevated CK, though some forms show hypertrophic cardiomyopathy 3.

Critical Distinction: The Opposite Pattern

Important caveat: The reverse pattern—elevated aldolase with normal CK—represents a completely different diagnostic category. This pattern is highly specific for myopathies with perimysial pathology, most commonly dermatomyositis 5, 6. In a recent cohort, dermatomyositis was the most common myopathy with selective aldolase elevation, featuring perimysial inflammation, fragmentation, or vasculitis in 50% of cases 6. When evaluating muscle discomfort or mild weakness with normal CK, always measure serum aldolase 5.

Practical Diagnostic Approach

When encountering elevated CK with normal or minimally elevated aldolase:

  1. Consider age and presentation: DMD typically diagnosed around age 5 with delayed walking, frequent falls, Gowers' sign 2
  2. Assess for systemic features: Hepatomegaly and hypoglycemia suggest GSD III 4; cardiomyopathy suggests Pompe disease or DMD 3, 2
  3. Evaluate exercise intolerance: Exercise-induced cramps and rhabdomyolysis point toward McArdle disease 4
  4. Check respiratory function: Diaphragm weakness is highly suggestive of Pompe disease, not typical of GSD III 4
  5. Pursue genetic testing: For dystrophinopathies, multiplex ligation-dependent probe amplification or PCR 2; for Pompe disease, GAA enzyme activity in cultured fibroblasts or dried blood spots 3

Monitoring Considerations

Sporadic inclusion body myositis deserves mention as it may show only minimally elevated CK despite progressive weakness 7. This occurs in patients over age 50 with insidious onset of asymmetric proximal and/or distal weakness, particularly affecting forearm flexors, finger flexors, and quadriceps 7.

The diagnostic utility of CK thresholds shows that baseline CK >1000 IU/L is highly predictive of inflammatory myopathy or neuromuscular disorders (PPV 90.3%) 8, making this a useful cutoff for pursuing aggressive diagnostic workup.

References

1
Research

[Enzymes and muscle diseases].

Reumatismo, 2001

3
Guideline

pompe disease diagnosis and management guideline.

Genetics in Medicine, 2006

Related Questions

What is the recommended management for a creatine kinase (CK) level of 1312 U/L?
In a 70-year-old woman with a brief, self-limited loss of sensation in both feet and a creatine kinase level of 241 U/L, what is the appropriate initial evaluation and management?
In a 47-year-old adult with a creatine kinase level of 468 U/L, what is the appropriate evaluation and management?
In a 32‑year‑old man with myalgias, leukocytosis and neutrophilia, does a normal creatine kinase (CK) exclude inflammatory muscle disease, and what further evaluation should be pursued?
What does an elevated aldolase level indicate?
How does hyperosmolar hyperglycemic state present clinically?
What serum aldolase level defines an abnormal result?
What is the ICD‑10‑CM code for a stage 2 pressure ulcer on the calf?
How much does Farxiga (dapagliflozin) lower HbA1c?
Can hypocalcemia cause a markedly elevated creatine kinase level with a normal aldolase?
What peptide supplement and dosing regimen is recommended for an adult with osteoarthritis‑related joint pain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.